JP2014500311A5 - - Google Patents

Download PDF

Info

Publication number
JP2014500311A5
JP2014500311A5 JP2013546072A JP2013546072A JP2014500311A5 JP 2014500311 A5 JP2014500311 A5 JP 2014500311A5 JP 2013546072 A JP2013546072 A JP 2013546072A JP 2013546072 A JP2013546072 A JP 2013546072A JP 2014500311 A5 JP2014500311 A5 JP 2014500311A5
Authority
JP
Japan
Prior art keywords
protein
ligand
domain
asparagine
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013546072A
Other languages
English (en)
Japanese (ja)
Other versions
JP5974343B2 (ja
JP2014500311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2011/051537 external-priority patent/WO2012087231A1/en
Publication of JP2014500311A publication Critical patent/JP2014500311A/ja
Publication of JP2014500311A5 publication Critical patent/JP2014500311A5/ja
Application granted granted Critical
Publication of JP5974343B2 publication Critical patent/JP5974343B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013546072A 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス Active JP5974343B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061424698P 2010-12-20 2010-12-20
US61/424,698 2010-12-20
PCT/SE2011/051537 WO2012087231A1 (en) 2010-12-20 2011-12-19 Affinity chromatography matrix

Publications (3)

Publication Number Publication Date
JP2014500311A JP2014500311A (ja) 2014-01-09
JP2014500311A5 true JP2014500311A5 (enExample) 2015-02-05
JP5974343B2 JP5974343B2 (ja) 2016-08-23

Family

ID=46314246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546072A Active JP5974343B2 (ja) 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス

Country Status (5)

Country Link
US (1) US9187555B2 (enExample)
EP (1) EP2654914B1 (enExample)
JP (1) JP5974343B2 (enExample)
CN (1) CN103269762B (enExample)
WO (1) WO2012087231A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9657055B2 (en) 2011-11-30 2017-05-23 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
US10189891B2 (en) * 2012-03-28 2019-01-29 Ge Healthcare Bioprocess R&D Ab Affinity chromatography matrix
MY178616A (en) 2012-09-17 2020-10-19 Grace W R & Co Chromatography media and devices
JP6544808B2 (ja) 2013-07-10 2019-07-17 ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ 突然変異免疫グロブリン結合ポリペプチド
SG11201605712SA (en) 2014-01-16 2016-08-30 Grace W R & Co Affinity chromatography media and chromatography devices
US11389783B2 (en) 2014-05-02 2022-07-19 W.R. Grace & Co.-Conn. Functionalized support material and methods of making and using functionalized support material
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
KR102566292B1 (ko) 2015-06-05 2023-08-10 더블유.알. 그레이스 앤드 캄파니-콘. 흡착성 바이오프로세싱 정화제와 이의 제조 및 사용 방법
WO2017014259A1 (ja) * 2015-07-22 2017-01-26 株式会社カネカ 酸性pH領域での抗体結合能が低下した抗体結合性タンパク質
JP6512308B2 (ja) * 2015-12-28 2019-05-15 株式会社島津製作所 クロマトグラフ
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
CN109071613A (zh) 2016-05-11 2018-12-21 通用电气医疗集团生物工艺研发股份公司 分离基质
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194592A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of storing a separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
US11753438B2 (en) 2016-05-11 2023-09-12 Cytiva Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
CN106543274B (zh) * 2016-10-18 2020-10-27 天津大学 一种对抗体具有特异性结合作用的a蛋白结构域z的衍生物及其应用
BR112019011921A2 (pt) 2016-12-12 2019-11-05 Hurrah S A R L polipeptídeo engenheirado que liga imunoglobulinas ou compostos contendo imunoglobulina, matriz de separação, composição, proteína, meio cromatográfico e método de purificação de uma imunoglobulina
GB201703116D0 (en) * 2017-02-27 2017-04-12 Ge Healthcare Bioprocess R&D Ab A seperation matrix and a method of seperating antibodies
WO2022081779A1 (en) 2020-10-13 2022-04-21 Avitide LLC Affinity ligand libraries of three-helix bundle proteins and uses thereof
EP4294542A1 (en) 2021-02-19 2023-12-27 Avitide LLC Aav2 affinity agents
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides
CN114939400B (zh) * 2022-06-28 2024-11-22 上海兆维科技发展有限公司 一种亲和层析填料及其制备方法以及亲和纯化工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505922D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US6602977B1 (en) 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
US7709209B2 (en) 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (sv) 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
SE0301987D0 (sv) * 2003-07-04 2003-07-04 Affibody Ab New polypeptide
SE0400274D0 (sv) 2004-02-09 2004-02-09 Affibody Ab New polypeptide
ATE490268T1 (de) * 2005-03-01 2010-12-15 Affibody Ab Tnf-alhpa-bindendes polypeptid, anwendungen davon und verfahren, bei denen dieses verwendet wird
JP5229888B2 (ja) * 2008-09-30 2013-07-03 独立行政法人産業技術総合研究所 弱酸性域での易解離性を向上したプロテインa変異型タンパク質及び抗体捕捉剤
CN102272145B (zh) * 2009-01-12 2014-07-30 通用电气健康护理生物科学股份公司 亲和色谱基质

Similar Documents

Publication Publication Date Title
JP2014500311A5 (enExample)
JP2014501758A5 (enExample)
JP2012515160A5 (enExample)
JP2014502272A5 (enExample)
Gaberc‐Porekar et al. Potential for using histidine tags in purification of proteins at large scale
DK2513134T3 (en) Washing solution and process for affinity chromatography
US10519195B2 (en) Antibody purification method, antibody obtained therefrom, novel antibody purification method using cation exchanger, and antibody obtained therefrom
Zhao et al. Biomimetic design of affinity peptide ligands for human IgG based on protein A-IgG complex
Zachariou et al. Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation
JP2007252368A5 (enExample)
JP2019531055A5 (enExample)
CN107001432A (zh) 突变的免疫球蛋白结合多肽
WO2011118599A1 (ja) アフィニティークロマトグラフィー用充填剤およびイムノグロブリンを単離する方法
JP2013514073A5 (enExample)
CN105377881A (zh) 突变的免疫球蛋白结合多肽
RU2014111820A (ru) Способы элиминации вируса
EP4371996A3 (en) Methods for purifying antibodies
US9534060B2 (en) Carrier for antibody purification, manufacturing method for same, and application for same
Nian et al. Void exclusion of antibodies by grafted-ligand porous particle anion exchangers
Roy et al. Current trends in affinity-based separations of proteins/enzymes
JP2015515969A5 (enExample)
Opitz et al. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography
JP2011001336A (ja) 新規なプロテインa固定化担体の製造方法
SE0402558D0 (sv) A process for the purification of antibodies
Brekkan Multimodal chromatography